ES503527A0 - Un procedimiento para la preparacion de compuestos marcromo-leculares de actividad mucolitica y no absorbibles por los tejidos - Google Patents

Un procedimiento para la preparacion de compuestos marcromo-leculares de actividad mucolitica y no absorbibles por los tejidos

Info

Publication number
ES503527A0
ES503527A0 ES503527A ES503527A ES503527A0 ES 503527 A0 ES503527 A0 ES 503527A0 ES 503527 A ES503527 A ES 503527A ES 503527 A ES503527 A ES 503527A ES 503527 A0 ES503527 A0 ES 503527A0
Authority
ES
Spain
Prior art keywords
absorbable
tissues
compounds
marcromo
lecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503527A
Other languages
English (en)
Other versions
ES8203420A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texcontor
Original Assignee
Texcontor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texcontor filed Critical Texcontor
Publication of ES8203420A1 publication Critical patent/ES8203420A1/es
Publication of ES503527A0 publication Critical patent/ES503527A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES503527A 1980-07-01 1981-06-30 Un procedimiento para la preparacion de compuestos marcromo-leculares de actividad mucolitica y no absorbibles por los tejidos Granted ES503527A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8023161A IT1209419B (it) 1980-07-01 1980-07-01 Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo.

Publications (2)

Publication Number Publication Date
ES8203420A1 ES8203420A1 (es) 1982-04-01
ES503527A0 true ES503527A0 (es) 1982-04-01

Family

ID=11204417

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503527A Granted ES503527A0 (es) 1980-07-01 1981-06-30 Un procedimiento para la preparacion de compuestos marcromo-leculares de actividad mucolitica y no absorbibles por los tejidos

Country Status (11)

Country Link
US (2) US4409138A (es)
EP (1) EP0045285B1 (es)
JP (1) JPS5813522A (es)
AT (1) ATE7202T1 (es)
AU (1) AU7241281A (es)
CA (1) CA1168169A (es)
DE (1) DE3163287D1 (es)
ES (1) ES503527A0 (es)
FR (1) FR2485925A1 (es)
IT (1) IT1209419B (es)
YU (1) YU163681A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
CA1317860C (en) * 1987-04-01 1993-05-18 Daniel Louis Kacian Techniques for preparing specimens for bacterial assays
US5128132A (en) * 1988-11-22 1992-07-07 Parnell Pharmaceuticals, Inc. Eriodictyon compositions and methods for treating internal mucous membranes
ES2252478T3 (es) * 2001-07-03 2006-05-16 Alcon, Inc. Composiciones para la remocion del cerumen humano.
US20060182705A1 (en) * 2005-02-11 2006-08-17 Cruse Maria K Composition for reduction and prevention of wrinkles on the skin
EP3797783A1 (en) * 2019-09-27 2021-03-31 Freie Universität Berlin Novel medical uses of thiol-functionalized polyglycerol derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR924877A (fr) * 1946-03-15 1947-08-19 Procédé de fabrication de préparations vétérinaires
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
NL6812443A (es) * 1968-08-31 1970-03-03
BE758425A (fr) * 1969-12-02 1971-04-16 Baxter Laboratories Inc Streptokinase liee chimiquement a une matrice en carbohydrate (
US3683069A (en) * 1970-02-19 1972-08-08 Michel Hooreman Enzymatic products which optimize the viscosity of mucuses and their applications
JPS5443074B1 (es) * 1971-04-14 1979-12-18
BE790326A (fr) * 1971-10-20 1973-04-19 Pechiney Ugine Kuhlmann Nouveau derive d'hydroxyquinoleine
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
GB1479268A (en) * 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
SE431758B (sv) * 1977-03-04 1984-02-27 Pharmacia Fine Chemicals Ab Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer
CS204190B1 (en) * 1978-02-22 1981-03-31 Jaroslav Drobnik Activation method for hydrxyl groups containing insoluble carriers
US4259233A (en) * 1979-10-23 1981-03-31 Miles Laboratories, Inc. β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates

Also Published As

Publication number Publication date
IT1209419B (it) 1989-07-16
FR2485925A1 (fr) 1982-01-08
US4409138A (en) 1983-10-11
ES8203420A1 (es) 1982-04-01
AU7241281A (en) 1982-01-07
JPS5813522A (ja) 1983-01-26
CA1168169A (en) 1984-05-29
EP0045285B1 (en) 1984-04-25
US4559322A (en) 1985-12-17
ATE7202T1 (de) 1984-05-15
FR2485925B1 (es) 1985-05-24
EP0045285A1 (en) 1982-02-03
DE3163287D1 (en) 1984-05-30
IT8023161A0 (it) 1980-07-01
YU163681A (en) 1983-09-30

Similar Documents

Publication Publication Date Title
ES496586A0 (es) Un procedimiento para la preparacion de un derivado enzimatico.
ES507310A0 (es) Procedimiento para la preparacion de derivados de urea.
ES519367A0 (es) Procedimiento para preparar derivados de ciclohexano-1,3-diona.
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
ES489149A0 (es) Un procedimiento para la preparacion de confituras congela- das.
ES503527A0 (es) Un procedimiento para la preparacion de compuestos marcromo-leculares de actividad mucolitica y no absorbibles por los tejidos
ES503878A0 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
AR222309A1 (es) Procedimiento para la elaboracion de 1,3-diaza-ciclo-pent-2-eno(2,1-b)-(1-tia-3-aza-cicloalcanos)
AR201067A1 (es) Procedimiento para la activacion de oxidasa de colesterina
ES520812A0 (es) Procedimiento para la preparacion de 3-azolil-1,2-diaril-1-halogeno-1-propenos.
MX7551E (es) Procedimiento mejorado para la isomerizacion enzimatica de glucosa en fructosa
ES519366A0 (es) Procedimiento para preparar derivados de ciclohexano-1,3-diona-5-fenil-sustituidos.
ES501154A0 (es) Procedimiento para la preparacion de anilidas de acidos tioglicolicos,substituidas con heterociclosmactivas como fungicidas
AR220127A1 (es) Procedimiento para la preparacion de d-homopregna-4,8-dieno-3,20-dionas
ES2070127T3 (es) Procedimiento para preparar n-acil-anilinas.
ES521460A0 (es) Procedimiento para preparar derivados de bencimidazol.
AR200674A1 (es) Procedimiento para la preparacion de 5-bromo-5-nitro-2-alquil-sustituido-1,3-dioxanos
ES523289A0 (es) Procedimiento para preparar derivados de cistamina.
ES232986Y (es) Bandeja para la practica de juegos, perfeccionada.
NO882494L (no) Ex vivo effektorcelleaktivering for maalcelledreping.
IT7822500A0 (it) Procedimento per la preparazione di mercaptani.
ES507345A0 (es) Procedimiento para la preparacion de nuevos analogos utiles de lincomicina y clindamicina.
ES235655Y (es) Disposicion perfeccionada de ensamblaje, para muebles modu- lares o similares.
ES522000A0 (es) Un procedimiento para tratar un material de glucosa antes de su conversion enzimatica en fructosa.
ES211113Y (es) Sujetador elastico para via con traviesa de madera.